These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2141586)

  • 1. Medroxyprogesterone acetate binding sites in human endometrium and endometrial cancer.
    Ohno Y; Fujibayashi H; Kitagawa I; Fujimoto Y; Okada H
    Gynecol Obstet Invest; 1990; 29(3):227-31. PubMed ID: 2141586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and comparison of receptors for 17 beta-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma.
    Pollow K; Lübbert H; Boquoi E; Kreuzer G; Pollow B
    Endocrinology; 1975 Feb; 96(2):319-28. PubMed ID: 234381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of medroxyprogesterone acetate in human breast cancer.
    Young PC; Keen FK; Einhorn LH; Stanich BM; Ehrlich CE; Cleary RE
    Am J Obstet Gynecol; 1980 Jun; 137(3):284-92. PubMed ID: 7377248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear progestin receptors in normal and malignant human endometrium.
    Feil PD; Mann WJ; Mortel R; Bardin CW
    J Clin Endocrinol Metab; 1979 Feb; 48(2):327-34. PubMed ID: 429486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
    Fujimoto J; Fujita H; Hosoda S; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of progesterone receptor in human endometrium with normal menstrual cycle, endometriosis or endometrial carcinoma (author's transl)].
    Watanabe K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):635-43. PubMed ID: 7240849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological localization of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate.
    Wood PL; Waites GT; MacVicar J; Davidson AC; Walker RA; Bell SC
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1292-8. PubMed ID: 2975952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
    Tanizawa O; Terakawa N
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):917-23. PubMed ID: 3389835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of danazol and medroxyprogesterone acetate on [3H]thymidine incorporation in human endometrial cancer cells.
    Terakawa N; Ikegami H; Shimizu I; Inoue M; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Jul; 31(1):131-5. PubMed ID: 2969434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro binding of progesterone to receptors in the human endometrium and the myometrium.
    Verma U; Laumas KR
    Biochim Biophys Acta; 1973 Aug; 317(2):403-19. PubMed ID: 19999724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
    Philipson KA; Elder MG; White JO
    J Steroid Biochem; 1985 Dec; 23(6A):1059-64. PubMed ID: 2936931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of receptors in the management of endometrial cancer.
    Richardson GS; MacLaughlin DT
    Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of sodium molybdate on the cytoplasmic estrogen and progesterone receptors in human endometrial tissues.
    Shyamala G; Ferenczy A
    Diagn Gynecol Obstet; 1981; 3(4):277-82. PubMed ID: 7200003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of medroxyprogesterone acetate binding in human endometrium: interaction with testosterone and progesterone binding sites.
    MacLaughlin DT; Richardson GS
    J Steroid Biochem; 1979 Apr; 10(4):371-7. PubMed ID: 449312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.